Why Zoetis Inc. (ZTS) stock moved
Zoetis Inc. (ZTS) shares tumbled 5.9% to $83.98 as of November 5, 2026, a significant decline from the prior close of $89.20. BestStocks flagged the session as a major change for ZTS. The move is tied to an earnings beat. Below, we break down what changed for ZTS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Earnings Beat
Zoetis Inc. (ZTS) reported EPS of $1.75 vs. consensus estimate of $1.51, beating by 15.9% on 2026-11-05. Monitor for any forward guidance updates or management commentary on demand trends in companion animal and livestock segments.
What it means for Zoetis Inc. investors
For Zoetis Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Earnings beat — stock sold off (sell-the-news reaction); Positive price momentum. Weighing against that: Sharp 5.9% decline — elevated risk; Zoetis reported Q3 2026 earnings and revenues that topped analyst estimates and raised full-year adjusted EPS guidance, yet the stock fell 5.20% to $84.56 by mid-session (Business Wire, Zacks). Wall Street's consensus price target sits at $84.75, implying +0.9% upside from $83.98. Over the past 90 days analysts logged 0 upgrades and 1 downgrade. BestStocks rates the overall signal quality medium (70/100). With earnings roughly 98 days out, the next report is the most likely near-term test of the move.
ZTS price reaction
ZTS last traded at $83.98, down $5.22 (-5.85%) from the previous close of $89.20. The session traded on 0.6× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $71.33 and $89.20, and it currently sits about 71% of the way up that band.
Bullish and bearish analyst opinions on Zoetis Inc. (ZTS)
The consensus analyst price target on Zoetis Inc. (ZTS) is $84.75, 0.9% above the recent $83.98. Over the past 90 days analysts logged 0 upgrades, 9 maintains, and 1 downgrade. Here is how the bullish and bearish cases on ZTS line up.
The bullish case
- Wall Street's consensus price target of $84.75 implies +0.9% upside from $83.98.
- The Street's most bullish target is $95.00 (+13.1%).
- Earnings beat — stock sold off (sell-the-news reaction).
- Positive price momentum.
The bearish case
- The most bearish analyst target is $74.00 (-11.9%).
- 1 analyst downgrade in the past 90 days, most recently Jefferies to Hold (2026-10-20).
- Sharp 5.9% decline — elevated risk.
- Zoetis reported Q3 2026 earnings and revenues that topped analyst estimates and raised full-year adjusted EPS guidance, yet the stock fell 5.20% to $84.56 by mid-session (Business Wire, Zacks).
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 5, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for ZTS
Frequently asked questions about ZTS
Why did Zoetis Inc. (ZTS) stock move?
ZTS tumbled 5.9% to $83.98. The move is associated with an earnings beat.
How much did ZTS stock fall?
ZTS lost 5.85% ($5.22) versus the prior close of $89.20, last trading at $83.98 on 0.6× average volume.
When is Zoetis Inc.'s next earnings date?
ZTS's next earnings report is estimated for 2027-02-11 — about 98 days away.
What is the analyst price target for ZTS?
The consensus analyst price target for ZTS is $84.75, about 0.9% above the current $83.98. Over the past 90 days, analysts recorded 0 upgrades, 9 maintains, and 1 downgrade.
How BestStocks tracks ZTS
This page is generated automatically by BestStocks' change-detection system after an earnings beat was detected and verified against independent data sources. It draws on 20 tracked change events for ZTS, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 5, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.